| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA711217 | F | Antiviral activity by measuring its effect on the accumulation of viral RNA transcripts on infection of MT-2 cells with HIV-1 RF. | Homo sapiens | 50 | cell-based format | Scientific Literature | ||
| 2. | ALA711378 | F | Antiviral potency evaluated by measuring accumulation of viral RNA transcripts 3 days after infection of MT-2 cells with HIV-1 RF | Homo sapiens | 53 | cell-based format | Scientific Literature | ||
| 3. | ALA711379 | F | Cellular antiviral activity (IC90) assessed on human MT-2 cells infected with HIV-RF | Homo sapiens | 24 | cell-based format | Scientific Literature | ||
| 4. | ALA711381 | F | Concentration which reduced the concentration of HIV viral RNA by 90% from the level measured in an untreated infected culture | Homo sapiens | 25 | cell-based format | Scientific Literature | ||
| 5. | ALA711383 | F | Concentration resulting in 90% inhibition of viral RNA production in HIV-1 infected MT-2 cells | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 6. | ALA711385 | T | Lethal dose (LD5) concentration inhibiting growth of MT-2 cells by 5% | Homo sapiens | 42 | cell-based format | Scientific Literature | ||
| 7. | ALA711386 | F | Cytotoxicity was determined by 50% reduction in the number of viable MT2 cells with HIV-1RF | Homo sapiens | 24 | cell-based format | Scientific Literature | ||
| 8. | ALA711392 | F | In vitro Cytotoxic concentration which destroyed HIV-1 LAV infected MT-2 cells completely | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 9. | ALA711393 | F | In vitro Cytotoxic concentration which destroyed HIV-1 LAV infected peripheral blood lymphocytes (PBL) completely | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 10. | ALA711394 | F | In vitro Cytotoxic concentration which reduced HIV-1 LAV infected MT-2 cells by 25 percent | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 11. | ALA711395 | F | Anti-HIV activity based on reduction of the viability of mock-infected MT-2 cells. | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 12. | ALA711396 | F | Cytotoxic concentration against MT-2 cells | Homo sapiens | 27 | cell-based format | Scientific Literature | ||
| 13. | ALA711397 | F | Cytotoxic concentration required to reduce the viability of mock-infected MT-2 cells by 50% | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 14. | ALA711398 | F | Effective concentration that increases formazan production in infected MT-2 cells | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
| 15. | ALA711399 | F | Tested for the antiviral activity against MT-2 cells infected with AZT resistant strain of HIV-1 (A012) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 16. | ALA711400 | F | Tested for the antiviral activity against MT-2 cells infected with AZT sensitive strain of HIV-1 (A012) | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 17. | ALA711401 | F | The compound was tested for its antiviral activity against HIV-1LAV virus infected MT-2 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 18. | ALA711403 | F | Anti-HIV activity based on inhibition of HIV-1 induced cytopathogenicity in MT-2 cells. | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
| 19. | ALA711404 | F | Compound was evaluated for its inhibitory activity against HIV-1-IIIB infected MT2 cells (human T lymphoid cells) | Homo sapiens | 8 | cell-based format | Scientific Literature | ||
| 20. | ALA711405 | F | Compound was tested for antiviral activity by measuring its ability to inhibit HIV induced cell killing in MT-2 cells | Homo sapiens | 3 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!